BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15665096)

  • 1. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo.
    Javed A; Barnes GL; Pratap J; Antkowiak T; Gerstenfeld LC; van Wijnen AJ; Stein JL; Lian JB; Stein GS
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1454-9. PubMed ID: 15665096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.
    Pratap J; Javed A; Languino LR; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Mol Cell Biol; 2005 Oct; 25(19):8581-91. PubMed ID: 16166639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells.
    Selvamurugan N; Kwok S; Partridge NC
    J Biol Chem; 2004 Jun; 279(26):27764-73. PubMed ID: 15084595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Runx2 induces bone osteolysis by transcriptional suppression of TSSC1.
    Wang DC; Wang HF; Yuan ZN
    Biochem Biophys Res Commun; 2013 Sep; 438(4):635-9. PubMed ID: 23933319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development.
    Choi JY; Pratap J; Javed A; Zaidi SK; Xing L; Balint E; Dalamangas S; Boyce B; van Wijnen AJ; Lian JB; Stein JL; Jones SN; Stein GS
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8650-5. PubMed ID: 11438701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal and spatial parameters of skeletal gene expression: targeting RUNX factors and their coregulatory proteins to subnuclear domains.
    Stein GS; Lian JB; Stein JL; van Wijnen AJ; Choi JY; Pratap J; Zaidi SK
    Connect Tissue Res; 2003; 44 Suppl 1():149-53. PubMed ID: 12952189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells.
    Barnes GL; Javed A; Waller SM; Kamal MH; Hebert KE; Hassan MQ; Bellahcene A; Van Wijnen AJ; Young MF; Lian JB; Stein GS; Gerstenfeld LC
    Cancer Res; 2003 May; 63(10):2631-7. PubMed ID: 12750290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains.
    Harrington KS; Javed A; Drissi H; McNeil S; Lian JB; Stein JL; Van Wijnen AJ; Wang YL; Stein GS
    J Cell Sci; 2002 Nov; 115(Pt 21):4167-76. PubMed ID: 12356919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene.
    Zaidi SK; Javed A; Choi JY; van Wijnen AJ; Stein JL; Lian JB; Stein GS
    J Cell Sci; 2001 Sep; 114(Pt 17):3093-102. PubMed ID: 11590236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
    Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of bone sialoprotein (BSP) and the pivotal transcriptional regulator of osteogenesis, Cbfa1/Runx2, in malignant melanoma.
    Riminucci M; Corsi A; Peris K; Fisher LW; Chimenti S; Bianco P
    Calcif Tissue Int; 2003 Sep; 73(3):281-9. PubMed ID: 14667142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Runx2 directed by the matrix metalloproteinase-13 promoter containing the AP-1 and Runx/RD/Cbfa sites alters bone remodeling in vivo.
    Selvamurugan N; Jefcoat SC; Kwok S; Kowalewski R; Tamasi JA; Partridge NC
    J Cell Biochem; 2006 Oct; 99(2):545-57. PubMed ID: 16639721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
    Taipaleenmäki H; Browne G; Akech J; Zustin J; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
    Cancer Res; 2015 Apr; 75(7):1433-44. PubMed ID: 25634212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway.
    Li XQ; Du X; Li DM; Kong PZ; Sun Y; Liu PF; Wang QS; Feng YM
    Cancer Res; 2015 Aug; 75(16):3302-13. PubMed ID: 26060017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
    Mendoza-Villanueva D; Zeef L; Shore P
    Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors.
    Lian JB; Javed A; Zaidi SK; Lengner C; Montecino M; van Wijnen AJ; Stein JL; Stein GS
    Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):1-41. PubMed ID: 15104525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
    Terry A; Kilbey A; Vaillant F; Stewart M; Jenkins A; Cameron E; Neil JC
    Gene; 2004 Jul; 336(1):115-25. PubMed ID: 15225881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease.
    Barnes GL; Hebert KE; Kamal M; Javed A; Einhorn TA; Lian JB; Stein GS; Gerstenfeld LC
    Cancer Res; 2004 Jul; 64(13):4506-13. PubMed ID: 15231660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone.
    Pratap J; Lian JB; Javed A; Barnes GL; van Wijnen AJ; Stein JL; Stein GS
    Cancer Metastasis Rev; 2006 Dec; 25(4):589-600. PubMed ID: 17165130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
    Chimge NO; Baniwal SK; Little GH; Chen YB; Kahn M; Tripathy D; Borok Z; Frenkel B
    Breast Cancer Res; 2011; 13(6):R127. PubMed ID: 22151997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.